Which sclerosing agent works best for vascular malformations? new study aims to find out
NCT ID NCT07320430
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared the effectiveness and safety of different sclerosing agents, including ethanol, for treating low-flow vascular malformations. Seventy-five participants with trunk or extremity lesions received injections under ultrasound guidance. The goal was to see which agent achieved the highest cure rate (complete or partial devascularization) with the fewest side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ethanol and other sclerosing agents
- What this could lead to
- If successful, this could identify the safest and most effective sclerosing agent for treating low-flow vascular malformations, improving outcomes and reducing complications.
- What could go wrong
- This is a completed small study (75 people) comparing existing treatments, so results may not apply to all patients. Risks include pain, skin issues, and allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR MALFORMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of medicine Ain Shams University
Cairo, Abbassia, 00202, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive HHT registry aims to unlock secrets of rare bleeding disorder
- Redesigned catheter aims to make angiograms safer and more precise
- New imaging technique could shed light on lymphatic disorders
- Could a transplant drug shrink Children's birthmarks?
- Neuro-Patch under the microscope: Real-World surgery study launched